Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease.

Belch, Jill J F
Brodmann, Marianne
Baumgartner, Iris
Binder, Christoph J
Casula, Manuela
Heiss, Christian
Kahan, Thomas
Parini, Paolo
Poredos, Pavel
Catapano, Alberico L
Tokgözoğlu, Lale

November 2021

Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events, but ...

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease:European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement

Belch, Jill J. F.
Brodmann, Marianne
Baumgartner, Iris
Binder, Christoph J.
Casula, Manuela
Heiss, Christian
Kahan, Thomas
Parini, Paolo
Poredos, Pavel
Catapano, Alberico L.
Tokgözoğlu, Lale

December 2021

Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events, but ...

Statins in patients at high risk of cardiovascular disease presenting with peripheral artery disease

Boland, Benoît
Goderis, G.

January 2004

This editorial refers to "Statin therapy improves cardiovascular outcome of patients with peripheral...

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

Pastori, Daniele
Farcomeni, Alessio
Milanese, Alberto
Del Sole, Francesco
Menichelli, Danilo
Hiatt, William R
Violi, Francesco

May 2020

Statins are guidelines recommended in patients with peripheral artery disease (PAD) for the prevent...

Statins and major adverse limb events in patients with peripheral artery disease. a systematic review and meta-analysis

Pastori, Daniele
Farcomeni, Alessio
Milanese, Alberto
Del Sole, Francesco
Menichelli, Danilo
Hiatt, William R
Violi, Francesco

January 2020

BACKGROUND:Statins are guidelines recommended in patients with peripheral artery disease (PAD) for t...

Statins and Peripheral Arterial Disease: A Narrative Review

Jansen-Chaparro, Sergio
López-Carmona, María D.
Cobos-Palacios, Lidia
Sanz-Cánovas, Jaime
Bernal-López, M. Rosa
Gómez-Huelgas, Ricardo

November 2021

Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients with ...

STATINS AND PERIPHERAL ARTERIAL DISEASE: EFFECTS ON DISEASE PROGRESSION, CLAUDICATION AND PREVENTION OF CARDIOVASCULAR EVENTS.

Coppola, G.
Novo, S.

January 2007

Peripheral arterial disease (PAD) of the lower limbs is the third most important site of atheroscler...

Use of statins in patients with peripheral artery disease

Corrado E.
Mignano A.
Coppola G.

January 2019

Atherosclerotic peripheral artery disease (PAD) is a growing health issue that affects more than 200...

Statins in Peripheral Arterial Disease

Chiesa, ST
Papageorgiou, N
Charakida, M

January 2017

Peripheral arterial disease (PAD) is a common atherosclertico condition affecting the lower extremit...

Association Between Statin Medications and Mortality, Major Adverse Cardiovascular Event, and Amputation-Free Survival in Patients With Critical Limb Ischemia

Westin, Gregory G.
Armstrong, Ehrin J.
Bang, Heejung
Yeo, Khung-Keong
Anderson, David
Dawson, David L.
Pevec, William C.
Amsterdam, Ezra A.
Laird, John R.

February 2014

ObjectivesThe aim of this study was to determine the associations between statin use and major adver...

Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry

Kumbhani, Dharam J.
Steg, Ph. Gabriel
Cannon, Christopher P.
Eagle, Kim A.
Smith, Sidney C.
Goto, Shinya
Ohman, E. Magnus
Elbez, Yedid
Sritara, Piyamitr
Baumgartner, Iris
Banerjee, Subhash
Creager, Mark A.
Bhatt, Deepak L.

January 2014

Due to a high burden of systemic cardiovascular events, current guidelines recommend the use of stat...

Statin Use and Functional Decline in Patients With and Without Peripheral Arterial Disease

Giri, Jay
McDermott, Mary M.
Greenland, Philip
Guralnik, Jack M.
Criqui, Michael H.
Liu, Kiang
Ferrucci, Luigi
Green, David
Schneider, Joseph R.
Tian, Lu

March 2006

ObjectivesWe determined whether statin use (vs. non-use) is associated with less annual decline in l...

Metabolic, endocrine and haemodynamic risk factors in the patient with peripheral arterial disease.

Belch, Jill J F

March 2002

The morbidity and mortality associated with peripheral arterial disease (PAD) creates a huge burden ...

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease

J.J.F. Belch
M. Brodmann
I. Baumgartner
C.J. Binder
M. Casula
C. Heiss
T. Kahan
P. Parini
P. Poredos
A.L. Catapano
L. Tokgozoglu

January 2021

Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events, but ...

Total Adiponectin and Risk of Symptomatic Lower Extremity Peripheral Artery Disease in Men

Joosten, Michel M.
Joshipura, Kaumudi J.
Pai, Jennifer K.
Bertoia, Monica L.
Rimm, Eric B.
Mittleman, Murray A.
Mukamal, Kenneth J.

May 2013

Objective-Lower concentrations of adiponectin have been linked to subsequent risk of coronary heart ...

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease.

Belch, Jill J F
Brodmann, Marianne
Baumgartner, Iris
Binder, Christoph J
Casula, Manuela
Heiss, Christian
Kahan, Thomas
Parini, Paolo
Poredos, Pavel
Catapano, Alberico L
Tokgözoğlu, Lale

November 2021

Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events, but ...

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease:European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement

Belch, Jill J. F.
Brodmann, Marianne
Baumgartner, Iris
Binder, Christoph J.
Casula, Manuela
Heiss, Christian
Kahan, Thomas
Parini, Paolo
Poredos, Pavel
Catapano, Alberico L.
Tokgözoğlu, Lale

December 2021

Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events, but ...

Statins in patients at high risk of cardiovascular disease presenting with peripheral artery disease

Boland, Benoît
Goderis, G.

January 2004

This editorial refers to "Statin therapy improves cardiovascular outcome of patients with peripheral...

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

Pastori, Daniele
Farcomeni, Alessio
Milanese, Alberto
Del Sole, Francesco
Menichelli, Danilo
Hiatt, William R
Violi, Francesco

May 2020

Statins are guidelines recommended in patients with peripheral artery disease (PAD) for the prevent...

Statins and major adverse limb events in patients with peripheral artery disease. a systematic review and meta-analysis

Pastori, Daniele
Farcomeni, Alessio
Milanese, Alberto
Del Sole, Francesco
Menichelli, Danilo
Hiatt, William R
Violi, Francesco

January 2020

BACKGROUND:Statins are guidelines recommended in patients with peripheral artery disease (PAD) for t...

Statins and Peripheral Arterial Disease: A Narrative Review

Jansen-Chaparro, Sergio
López-Carmona, María D.
Cobos-Palacios, Lidia
Sanz-Cánovas, Jaime
Bernal-López, M. Rosa
Gómez-Huelgas, Ricardo

November 2021

Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients with ...

STATINS AND PERIPHERAL ARTERIAL DISEASE: EFFECTS ON DISEASE PROGRESSION, CLAUDICATION AND PREVENTION OF CARDIOVASCULAR EVENTS.

Coppola, G.
Novo, S.

January 2007

Peripheral arterial disease (PAD) of the lower limbs is the third most important site of atheroscler...

Use of statins in patients with peripheral artery disease

Corrado E.
Mignano A.
Coppola G.

January 2019

Atherosclerotic peripheral artery disease (PAD) is a growing health issue that affects more than 200...

Statins in Peripheral Arterial Disease

Chiesa, ST
Papageorgiou, N
Charakida, M

January 2017

Peripheral arterial disease (PAD) is a common atherosclertico condition affecting the lower extremit...

Association Between Statin Medications and Mortality, Major Adverse Cardiovascular Event, and Amputation-Free Survival in Patients With Critical Limb Ischemia

Westin, Gregory G.
Armstrong, Ehrin J.
Bang, Heejung
Yeo, Khung-Keong
Anderson, David
Dawson, David L.
Pevec, William C.
Amsterdam, Ezra A.
Laird, John R.

February 2014

ObjectivesThe aim of this study was to determine the associations between statin use and major adver...

Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry

Kumbhani, Dharam J.
Steg, Ph. Gabriel
Cannon, Christopher P.
Eagle, Kim A.
Smith, Sidney C.
Goto, Shinya
Ohman, E. Magnus
Elbez, Yedid
Sritara, Piyamitr
Baumgartner, Iris
Banerjee, Subhash
Creager, Mark A.
Bhatt, Deepak L.

January 2014

Due to a high burden of systemic cardiovascular events, current guidelines recommend the use of stat...

Statin Use and Functional Decline in Patients With and Without Peripheral Arterial Disease

Giri, Jay
McDermott, Mary M.
Greenland, Philip
Guralnik, Jack M.
Criqui, Michael H.
Liu, Kiang
Ferrucci, Luigi
Green, David
Schneider, Joseph R.
Tian, Lu

March 2006

ObjectivesWe determined whether statin use (vs. non-use) is associated with less annual decline in l...

Metabolic, endocrine and haemodynamic risk factors in the patient with peripheral arterial disease.

Belch, Jill J F

March 2002

The morbidity and mortality associated with peripheral arterial disease (PAD) creates a huge burden ...

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease

J.J.F. Belch
M. Brodmann
I. Baumgartner
C.J. Binder
M. Casula
C. Heiss
T. Kahan
P. Parini
P. Poredos
A.L. Catapano
L. Tokgozoglu

January 2021

Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events, but ...

Total Adiponectin and Risk of Symptomatic Lower Extremity Peripheral Artery Disease in Men

Joosten, Michel M.
Joshipura, Kaumudi J.
Pai, Jennifer K.
Bertoia, Monica L.
Rimm, Eric B.
Mittleman, Murray A.
Mukamal, Kenneth J.

May 2013

Objective-Lower concentrations of adiponectin have been linked to subsequent risk of coronary heart ...

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease.

Belch, Jill J F
Brodmann, Marianne
Baumgartner, Iris
Binder, Christoph J
Casula, Manuela
Heiss, Christian
Kahan, Thomas
Parini, Paolo
Poredos, Pavel
Catapano, Alberico L
Tokgözoğlu, Lale

November 2021

Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events, but ...

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease:European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement

Belch, Jill J. F.
Brodmann, Marianne
Baumgartner, Iris
Binder, Christoph J.
Casula, Manuela
Heiss, Christian
Kahan, Thomas
Parini, Paolo
Poredos, Pavel
Catapano, Alberico L.
Tokgözoğlu, Lale

December 2021

Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events, but ...

Statins in patients at high risk of cardiovascular disease presenting with peripheral artery disease

Boland, Benoît
Goderis, G.

January 2004

This editorial refers to "Statin therapy improves cardiovascular outcome of patients with peripheral...

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

Abstract

Extracted data

Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis

Abstract

Extracted data

Related items

Related items